GlaxoSmithKline PLC — Director's Dealing 2015

Jul 20, 2015

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5212T

GlaxoSmithKline PLC

20 July 2015

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging

Managerial Responsibilities or Connected Persons

In accordance with DTR 3.1.4R(1)(a) GlaxoSmithKline plc ('GSK') was advised on 20 July 2015, of changes in the interests of the following Directors and Persons Discharging Managerial Responsibilities ('PDMR'), following increases in their notional interests in Ordinary Shares and American Depositary Shares (ADSs), at a price of 1350.50 pence per Ordinary Share and $41.36 per ADS, following the re-investment of dividends paid on Ordinary Shares and ADSs held in the GlaxoSmithKline 2009 Deferred Annual Bonus Plan.

Director/PDMR	Number of Ordinary Shares acquired under the personal contribution element of the plan	Number of Ordinary Shares acquired under the matching element of the plan (GSK contribution)
Sir Andrew Witty	1780	1780
Mr S Dingemans	679	679
Mr R G Connor	353	353
Mr N Hirons	76	76
Mr S A Hussain	304	304
Mr D S Redfern	379	379
Ms C Thomas	260	260
Mr P C Thomson	127	127
Dr P J T Vallance	910	910
Ms E Walmsley	537	537

Director/PDMR	Number of ADSs acquired under the personal contribution element of the plan	Number of ADSs acquired  under the matching element of the plan (GSK contribution)
Dr M M Slaoui	694	694
Mr W C Louv	178	178
Mr D E Troy	292	292

V A Whyte

Company Secretary

20 July 2015

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSFBLFLEDFFBBK